SERB Pharmaceuticals
Luxembourg · Founded 1951
About SERB Pharmaceuticals
SERB Pharmaceuticals is a specialty pharmaceutical company that focuses on the treatment of patients with critical conditions. The company's primary focus is on emergency care and rare diseases. SERB Pharmaceuticals is a combination of SERB, BTG Specialty Pharmaceuticals, and Veriton Pharma, forming a growing specialty pharmaceutical entity. The company also aims to build up management systems that match global practices in the promotion and funding of basic research. They have developed a scheme called SERB-SUPRA for scientific and useful profound research, including drug discovery and the study of chemical toxicity.
Company Facts
- Founded: 1951
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Website: http://www.serb.com
- Phone: 352 26 20 12 16
Industries & Categories
Emergency Medicine, Health Care, Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/serb-pharmaceuticals-2221715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.